Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUROPAC2 trial of ANTOX(vers) 1.2 and magnesium (Magnesiocard) in hereditary and idiopathic chronic pancreatitis
2006-000087-83Phase 3Unknown
- Sponsor
- University of Liverpool
- Start
- Dec 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ascorbic acid, methionine and magnesium l-aspartate hydrochloride trihydrate in Familial Pancreatitis, Chronic idiopathic pancreatitis (CIP), acute pancreatitis (AP) and 1 more, sponsored by University of Liverpool. Primary endpoint: Reduction in number of days of pancreatic pain during 12 continuous months of treatment. Status: unknown.
02
Drugs
ascorbic acidmethioninemagnesium l-aspartate hydrochloride trihydrate
03
Conditions
Familial PancreatitisChronic idiopathic pancreatitis (CIP)acute pancreatitis (AP)chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2006-000087-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000087-83.